2014
DOI: 10.11622/smedj.2014066
|View full text |Cite
|
Sign up to set email alerts
|

Intra-articular glucocorticoid injections in patients with juvenile idiopathic arthritis in a Singapore hospital

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 21 publications
0
3
0
Order By: Relevance
“…Ravelli et al (8) reported that 52% of children achieved remission in injected joints, similar to Neidel et al (9) and Cuncha et al (10) who reported full remission of joint inflammation in 58-82% and more than 50% of large joints of children enrolled in their study. As TH has a lower solubility compared to TA, its absorption from the injected joint is slower, thereby maintaining synovial levels for a longer period, which may account for its enhanced efficacy (2,11,12). The results obtained by Zulian et al (13) clearly showed that after 6 months 81.4% of joints injected with TH and 53.3% of joints injected with TA had no sign of inflammation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Ravelli et al (8) reported that 52% of children achieved remission in injected joints, similar to Neidel et al (9) and Cuncha et al (10) who reported full remission of joint inflammation in 58-82% and more than 50% of large joints of children enrolled in their study. As TH has a lower solubility compared to TA, its absorption from the injected joint is slower, thereby maintaining synovial levels for a longer period, which may account for its enhanced efficacy (2,11,12). The results obtained by Zulian et al (13) clearly showed that after 6 months 81.4% of joints injected with TH and 53.3% of joints injected with TA had no sign of inflammation.…”
Section: Discussionmentioning
confidence: 99%
“…Juvenile idiopathic arthritis (JIA) is a chronic rheumatic disease of unknown cause, most common in childhood and a significant cause of disability in children (1). Various therapeutic options have been recommended to control inflammation and prevent permanent loss of joint function (2). The intraarticular steroids (IASs) are a commonly used option for the treatment in children with JIA with a small number of affected joints as well as an effective way to reduce and/or avoid the use of systemic drugs, to treat an arthritis flare in children already maintained on second-line agents (3,4).…”
Section: Introductionmentioning
confidence: 99%
“…This is supported by an audit on intra-articular steroid injections performed in JIA patients in NUH. (4) The audit showed that joint injections were performed only once in 80.8% of patients with good clinical response and that no incidence of septic arthritis or avascular necrosis was recorded. Physiotherapy and occupational therapy complement therapeutic effort to achieve complete disease quiescence, enabling the child to have a normal life and function.…”
mentioning
confidence: 99%